Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Abstract Background Rapidly progressive interstitial lung disease (RP-ILD) is a severe, often fatal complication in patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5+ DM). Early prediction of RP-ILD still remains challenging. We aimed to explore th...
Saved in:
| Main Authors: | Yun Wu, Yue Wang, Yulu Qiu, Chengying Lv, Yujing Zhu, Lei Wang, Lingxiao Xu, Hanxiao You, Fang Wang, Wenfeng Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03921-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics and outcomes of anti-MDA5 dermatomyositis: a retrospective study
by: Tulaton Sodsri, et al.
Published: (2025-08-01) -
Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study
by: Hongxia Xin, et al.
Published: (2025-01-01) -
Anti-MDA-5 dermatomyositis with tumid lupus-like lesions
by: Kristiana Marie Jordan, BA, et al.
Published: (2025-06-01) -
Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01) -
Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis
by: Akira Yoshida, et al.
Published: (2025-07-01)